Drug Profile
Research programme: melanocortin-4 receptor antagonists - Gene Logic
Alternative Names: Melanocortin-4 receptor antagonists research programme - Gene LogicLatest Information Update: 27 Jul 2004
Price :
$50
*
At a glance
- Originator Gene Logic
- Class
- Mechanism of Action Melanocortin type 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cachexia
Most Recent Events
- 27 Jul 2004 Gene Logic has acquired the MC4 antagonist research programme from Millennium Pharmaceuticals
- 04 Jun 2004 Discontinued - Preclinical for Cachexia in USA (unspecified route)
- 23 Jul 1999 Preclinical development for Cachexia in USA (Unknown route)